Influence of endothelial nitric oxide synthase haplotypes on nitric oxide and peroxynitrite productions

Bioelectrochemistry. 2025 Feb:161:108837. doi: 10.1016/j.bioelechem.2024.108837. Epub 2024 Oct 16.

Abstract

The impact of four clinically significant genetic variants of endothelial nitric oxide synthase (eNOS) polymorphisms on the concentrations of nitric oxide [NO] and peroxynitrite [ONOO-] has been given scant consideration. This study utilized a [NO]/[ONOO-] ratio to determine the extent of endothelial dysfunction caused by these variations in the eNOS gene. The single nucleotide polymorphisms (T-786C, C-665T, and Glu298Asp) and a variable number of tandem repeats (intron 4 a/b/c) were genotyped in human umbilical vein endothelial cells (HUVEC), using sanger sequencing and DNA electrophoresis, respectively. Nanosensors were used to determine the maximal [NO] and [ONOO-], while traditional and low-temperature SDS-PAGE were used to evaluate the expression of eNOS and the eNOS dimer-to-monomer ratio, respectively. The study results indicate that the eNOS haplotype H3 (G T/C C 4a/c allele) may have a protective effect against cardiovascular disease (CVD) with the [NO]/[ONOO-] ratio higher than 2. However, the eNOS haplotypes H2 (G T/C C 4a/b) and H5 (T T/C C 4b) increase the susceptibility to CVD with [NO]/[ONOO-] ratio lower than 1. The results suggest that certain eNOS genetic variants may influence susceptibility to cardiovascular disease (CVD) while other variants may have a protective effect.

Keywords: Endothelial dysfunction; Nanosensor; eNOS gene; eNOS monomer/dimer; eNOS uncoupling.

MeSH terms

  • Haplotypes*
  • Human Umbilical Vein Endothelial Cells* / metabolism
  • Humans
  • Nitric Oxide Synthase Type III* / genetics
  • Nitric Oxide Synthase Type III* / metabolism
  • Nitric Oxide* / metabolism
  • Peroxynitrous Acid* / metabolism
  • Polymorphism, Single Nucleotide*

Substances

  • Nitric Oxide Synthase Type III
  • Peroxynitrous Acid
  • Nitric Oxide
  • NOS3 protein, human